Eli Lilly's growth is impressive, but its current valuation is only justifiable with sustained high growth. Click here to ...

Novo Nordisk (NVO) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider ...

Novo Nordisk NVO and Viking Therapeutics VKTX have emerged as notable players in the obesity space. A market leader in the ...

Just 14 stocks with market caps above $1 billion have doubled so far this year. They probably aren't the winners you would ...

AbbVie posted strong Q1 2025 results and raised guidance, but early-stage obesity pipeline and fair valuation limit upside.

How Ozempic’s Maker Lost Its Grip on the Obesity Market It Created ...

Nevertheless, European companies have found themselves in the sights of America’s president, who is irked by the fact that ...

Internationally, the scale is far smaller. There is not a single public company outside the US currently worth $1 trillion.

RB Advisors most recent paper The Mag 7 becomes the Mid 7 (I am 90 per cent certain Mr. Bernstein himself wrote it) talks ...

Ozempic helped Novo Nordisk gain an early lead in the weight loss industry, but competition is nipping at the company's heels ...

Whichever way the tariff winds blow (and I've no special knowledge of that), Novo Nordisk stock remains arguably the cheapest ...